4th Quarter - Report
TIBER CREEK GROUP for VERTEX PHARMACEUTICALS
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2012 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| SEAN RICHARDSON | — |
Health Issues HCR
Issues related to raising awareness of Hepatitis C. Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions. FY 2012 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding. H.R. 2045, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011. Reauthorization of the Prescription Drug User Fee Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| SEAN RICHARDSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.